AU2021106749A4 - Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder - Google Patents
Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder Download PDFInfo
- Publication number
- AU2021106749A4 AU2021106749A4 AU2021106749A AU2021106749A AU2021106749A4 AU 2021106749 A4 AU2021106749 A4 AU 2021106749A4 AU 2021106749 A AU2021106749 A AU 2021106749A AU 2021106749 A AU2021106749 A AU 2021106749A AU 2021106749 A4 AU2021106749 A4 AU 2021106749A4
- Authority
- AU
- Australia
- Prior art keywords
- whey protein
- group
- peptide
- protein powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010046377 Whey Proteins Proteins 0.000 title claims abstract description 119
- 235000021119 whey protein Nutrition 0.000 title claims abstract description 119
- 102000007544 Whey Proteins Human genes 0.000 title claims abstract description 118
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 70
- 239000000843 powder Substances 0.000 title claims abstract description 57
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 36
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 235000018102 proteins Nutrition 0.000 title claims abstract description 35
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- 230000000694 effects Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000012528 membrane Substances 0.000 claims abstract description 18
- 239000004365 Protease Substances 0.000 claims description 29
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 25
- 239000000796 flavoring agent Substances 0.000 claims description 23
- 235000019634 flavors Nutrition 0.000 claims description 23
- 241000699670 Mus sp. Species 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 108091005804 Peptidases Proteins 0.000 claims description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 15
- 230000009849 deactivation Effects 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 235000019419 proteases Nutrition 0.000 claims description 15
- 108090000526 Papain Proteins 0.000 claims description 14
- 229940055729 papain Drugs 0.000 claims description 14
- 235000019834 papain Nutrition 0.000 claims description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 10
- 229960003604 testosterone Drugs 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 9
- 108010035532 Collagen Proteins 0.000 claims description 9
- 239000004376 Sucralose Substances 0.000 claims description 9
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 229940024606 amino acid Drugs 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 229920001436 collagen Polymers 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 9
- 235000019408 sucralose Nutrition 0.000 claims description 9
- 230000001877 deodorizing effect Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 108091006112 ATPases Proteins 0.000 claims description 6
- 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 6
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 238000007689 inspection Methods 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 description 10
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 8
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 6
- 239000000413 hydrolysate Substances 0.000 description 6
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 4
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000000265 homogenisation Methods 0.000 description 4
- 210000003470 mitochondria Anatomy 0.000 description 4
- 230000037257 muscle growth Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000001364 upper extremity Anatomy 0.000 description 4
- 102000013275 Somatomedins Human genes 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000004155 insulin signaling pathway Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000014156 AMP-Activated Protein Kinases Human genes 0.000 description 2
- 108010011376 AMP-Activated Protein Kinases Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000011022 operating instruction Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 235000021075 protein intake Nutrition 0.000 description 2
- 210000003314 quadriceps muscle Anatomy 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 102000013698 Cyclin-Dependent Kinase 6 Human genes 0.000 description 1
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000000891 luminescent agent Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000004096 skeletal muscle tissue growth Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003656 tris buffered saline Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
OF THE DISCLOSURE
The present disclosure provides a whey protein peptide with a muscle-building effect and a
preparation method thereof, and a compound protein powder, relating to the technical field of
protein peptides. In the present disclosure, a whey protein is hydrolyzed to obtain a whey protein
peptide using a whey protein isolate as a raw material, and through a selective enzymolysis and a
nano-scale membrane treatment system. The muscle-building efficacy of the whey protein peptide
is verified using animal experiments. It is found that the muscle-building effect of the whey protein
peptide is significantly better than that of a whey protein powder.
Description
[01] The present disclosure belongs to the technical field of protein peptides, and specifically relates to a whey protein peptide with a muscle-building effect and a preparation method thereof, and a compound protein powder.
[02] After 25 years of age, various functions of the human body will gradually decrease. The human body has the most muscle mass at 20-25 years of age, and then will gradually lose the muscle. The muscle mass will lose by 10% within about 10 years, leading to a decrease of the strength accordingly.
[03] A certain frequency of strength training is one of the effective means to maintain muscles. Exercise not only consumes a lot of energy, but also intensifies protein catabolism, and may even cause a negative balance of protein. Therefore, the protein intake should be increased, and especially the protein intake should be increased. Although an intake increase of the common protein powders in an appropriate amount, such as a whey protein, is important in supplementing the protein loss during exercise, increasing the muscle strength, promoting the hemoglobin synthesis, and eliminating the fatigue, etc. However, there are problems of difficult digestion and slightly insufficient muscle-building effect.
[04] In view of this, the present disclosure provides a whey protein peptide with a muscle-building effect and a preparation method thereof, and a compound protein powder. The whey protein peptide is easier to be absorbed due to a small molecular weight, and has a significant muscle-building effect.
[05] In order to realize the above objective, the present disclosure provides the following technical solutions:
[06] The present disclosure provides a preparation method of a whey protein peptide, including the following steps: (1) preparing a whey protein powder into a whey protein aqueous solution, adjusting a pH of the whey protein aqueous solution to 8.5-8.8, and conducting heat preservation at 53-56°C for 25-30 min to obtain a homogenate; where the whey protein powder and water in the whey protein aqueous solution have a mass-to-volume ratio of 1 kg: (8-12) L; and
[07] (2) conducting enzymolysis on the homogenate using a papain and a flavor protease, decolorizing and deodorizing after enzyme deactivation, collecting a submembrane liquid of a 1 kDa organic membrane to obtain the whey protein peptide.
[08] Preferably, in step (1), a preparation method of the whey protein aqueous solution may include: dissolving 3 0 -5 0 % of the whey protein powder with 3 0 -5 0 % of water, stirring uniformly and adding the remaining water and whey protein powder.
[09] Preferably, in step (1), the pH may be adjusted to 8.5-8.8 using a NaOH solution with a concentration of 10 mol/L.
[10] Preferably, in step (2), the papain may be 0.8-1.2% the mass of the whey protein powder, and the flavor protease may be 0.4-0.6% the mass of the whey protein powder.
[11] Preferably, in step (2), the enzymolysis may include: mixing the homogenate with the papain for enzymolysis for 3 h, and then with the flavor protease for enzymolysis for 2 h.
[12] Preferably, in step (2), the decolorizing and deodorizing may be conducted with an activated carbon; and
[13] a decolorized and deodorized enzyme deactivation liquid may be passed through a ceramic membrane with a molecular weight cut-off of 30,000 Da and an organic membrane with a molecular weight cut-off of 1,000 Da sequentially, and the submembrane liquid may be collected.
[14] Preferably, the preparation method may further include: spray drying after collecting the submembrane liquid.
[15] The present disclosure further provides a whey protein peptide obtained by the preparation method, where a branched chain amino acid in the whey protein peptide has a mass percentage of more than 20%.
[16] The present disclosure further provides a compound protein powder with a muscle-building effect, including a whey protein, a collagen peptide, a food flavor, a sucralose and the whey protein peptide.
[17] Preferably, the compound protein powder includes the following components by mass percentage: the whey protein 60-70%, the whey protein peptide 25-36%, the collagen peptide 1-2%, the food flavor 1-2% and the sucralose 0.04-0.1%.
[18] The beneficial effects are as follows: in the present disclosure, a whey protein is hydrolyzed to obtain a whey protein peptide using a whey protein isolate as a raw material, and through a selective enzymolysis and a nano-scale membrane treatment system. The muscle-building efficacy of the whey protein peptide is verified using animal experiments. It is found that the muscle-building effect of the whey protein peptide is significantly better than that of a whey protein powder.
[19] FIG. 1 is a whey protein peptide data report issued by Shandong Tianheng Inspection Co., Ltd.
[20] FIG. 2 is grip strength of forelimbs of different groups of mice.
[21] FIG. 3 is a testosterone content of different groups of mice.
[22] FIG. 4 is a content of insulin-like growth factor 1 (IGF-1) in serum of different groups of mice.
[23] FIG. 5 is an adenosine triphosphatase (ATPase) activity in skeletal muscle mitochondria of different groups of mice.
[24] FIG. 6 is a pea oligopeptide activating an insulin-like growth factor (IGF)/insulin-like growth factor 1 receptor (IGF-1R) signaling pathway.
[25] The present disclosure provides a preparation method of a whey protein peptide, including the following steps: (1) preparing a whey protein powder into a whey protein aqueous solution, adjusting a pH of the whey protein aqueous solution to 8.5-8.8, and conducting heat preservation at 53-56°C for 25-30 min to obtain a homogenate; where the whey protein powder and water in the whey protein aqueous solution have a mass-to-volume ratio of 1 kg: (8-12) L; and
[26] (2) conducting enzymolysis on the homogenate using a papain and a flavor protease, decolorizing and deodorizing after enzyme deactivation, collecting a submembrane liquid of a 1 kDa organic membrane to obtain the whey protein peptide.
[27] In the present disclosure, a whey protein powder is prepared into a whey protein aqueous solution, the pH of the whey protein aqueous solution is adjusted to 8.5-8.8, and heat preservation is conducted at 53-56°C for 25-30 min to obtain a homogenate; where the whey protein powder and water in the whey protein aqueous solution have a mass-to-volume ratio of 1 kg: (8-12) L. A preparation method of the whey protein aqueous solution preferably includes: dissolving 30-50% of the whey protein powder with 30-50% of water, stirring uniformly and adding the remaining water and whey protein powder. In an example, when 500 kg of the whey protein powder is used to prepare a solution, 2000 L of a deionized water is added, 200 kg of the whey protein powder is added to the water while stirring at a rate of 200 r/min; and 3000 L of the deionized water is added, and the remaining 300 kg of the whey protein powder is added while stirring at a rate of 200 r/min. There is no special limitation on the source of the whey protein powder, and a commercially-available whey protein isolate conventional in the art may be used.
[28] In the present disclosure, the pH of the whey protein aqueous solution is adjusted to 8.5-8.8 preferably using a NaOH solution with a concentration of 10 mol/L; and heat preservation is conducted at 53-56°C for 25-30 min.
[29] In the present disclosure, enzymolysis is conducted on the homogenate using a papain and a flavor protease, decolorizing and deodorizing are conducted after enzyme deactivation, and a submembrane liquid of a 1 kDa organic membrane is collected to obtain the whey protein peptide.
The enzymolysis preferably includes: mixing the homogenate with the papain for enzymolysis for 3 h, and then with the flavor protease for enzymolysis for 2 h. The papain is 0.8-1.2% the mass of the whey protein powder, more preferably 1%. The flavor protease is 0.4-0.6% the mass of the whey protein powder, more preferably 0.5%. In an example, preferably the papain is added to the homogenate twice within 30 min, where the two addition amounts are the same; and the enzymolysis is conducted for 3 h by starting timing after the second addition. The flavor protease is preferably added at one time for enzymolysis for 2 h. There is no special limitation on the sources of the papain and the flavor protease, and commercially-available papain and flavor protease conventional in the art may be used.
[30] In the present disclosure, the enzyme deactivation is preferably conducted by heating an enzymatic hydrolysate at 85-90°C for 5 min. The decolorizing and deodorizing of the enzymatic hydrolysate after enzyme deactivation preferably includes: cooling an enzyme deactivation solution to 50-53°C, adjusting the pH of the enzyme deactivation solution to 4.5-5.0 using a 1OM HCl, and adding an activated carbon to the enzyme deactivation solution and maintaining for 90-110 min. The activated carbon is preferably 4% the mass of the whey protein powder. The decolorized and deodorized enzyme deactivation solution is preferably passed through a ceramic membrane with a molecular weight cut-off of 30,000 Da and an organic membrane with a molecular weight cut-off of 1,000 Da sequentially, and the submembrane liquid is collected.
[31] In the present disclosure, the preparation method preferably further includes: spray drying with an inlet air temperature of 180°C, and an outlet air temperature of 140°C after collecting the submembrane liquid.
[32] The present disclosure further provides a whey protein peptide obtained by the preparation method, where a branched chain amino acid in the whey protein peptide has a mass percentage of more than 20%. The whey protein peptide has a protein content of more than 91%. In an example, the obtained whey protein peptides with a molecular weight of less than 1,000 Da account for more than 85%, which are easier to be absorbed by the human body; the whey protein peptide has a proportion of branched chain amino acids reaching 20.8%; and the finally obtained whey protein peptide has no lactose, which is more suitable for oriental physique.
[33] The present disclosure further provides a compound protein powder with a muscle-building effect, including a whey protein, a collagen peptide, a food flavor, a sucralose and the whey protein peptide.
[34] The compound protein powder preferably includes the following components by mass percentage: the whey protein 60- 7 0%, the whey protein peptide 25- 3 6 %, the collagen peptide 1- 2 %, the food flavor 1- 2 % and the sucralose 0.0 4 -0.1%; more preferably, the whey protein 6 6 .7 4 %, the whey protein peptide 30.2%, the collagen peptide 1.5%, the food flavor 1.5% and the sucralose 0.06%. There is no special limitation on a preparation method of the compound protein powder, and a preparation method conventional in the art, such as stirring, may be used.
[35] The whey protein peptide with a muscle-building effect and a preparation method thereof, and a compound protein powder provided in the present disclosure will be described in detail below with reference to examples, but these examples cannot be understood as limiting the claimed protection scope of the present disclosure.
[36] Example 1
[37] Production process of a whey protein peptide
[38] (1) 2,000 L of deionized water was added to an enzymolysis tank, and 200 kg of a whey protein powder was added to the enzymolysis tank while stirring at a rate of 200 r/min; and 3,000 L of the deionized water was added to the enzymolysis tank, and the remaining 300 kg of the whey protein powder was added to the enzymolysis tank while stirring at a rate of 200 r/min.
[39] (2) A pH of a homogenate obtained in step (1) was adjusted to 8.5-8.8 with a OM NaOH, and heated to 53-56°C for 25-30 min while maintaining the pH.
[40] (3) 5 kg of a papain was weighed and added to an adjusted slurry obtained in step (2) twice in the same amount within 30 min, and enzymolysis was conducted for 3 h to obtain an enzymatic hydrolysate; 2.5 kg of a flavor protease was weighed and added to the enzymatic hydrolysate at one time, and enzymolysis was continued for 2 h; and temperature was raised to 85-90°C for 5 min to inactivate the protease.
[41] (4) An enzyme deactivation solution was cooled to 50-53°C, the pH of the enzyme deactivation solution was adjusted to 4.5-5.0 using a 1OM HCl, and 20 kg of an activated carbon was weighed and added to the enzyme deactivation solution and maintained for 90-110 min.
[42] (5) The enzymatic hydrolysate treated by the activated carbon was passed through a ceramic membrane with a molecular weight cut-off of 30,000 Da and an organic with a molecular weight cut-off of 1,000 Da sequentially.
[43] (6) The enzymatic hydrolysate of a whey protein peptide obtained by the membrane treatment was spray-dried with an inlet air temperature of 180°C and an outlet air temperature of 140°C, to obtain the whey protein peptide.
[44] The physical and chemical indexes (m/m) of the obtained whey protein peptides were: protein content 91.3%, moisture 5.1%, and ash content 3 .6 %; the whey protein peptides with a molecular weight of less than 1,000 Da account for more than 85%, which are easier to be absorbed by the human body; the whey protein peptide has a proportion of branched chain amino acids reaching 20.8%; and the finally obtained whey protein peptide has no lactose, which is more suitable for oriental physique.
[45] Meanwhile, Shandong Tianheng Inspection Co., Ltd. was commissioned to determine the distribution and molecular weight of hydrolyzed amino acids in the whey protein peptide (Table 1 and FIG. 1). The molecular weight distribution results (peak area percentage, %,X220nm) were as follows: >3000 0.07%, 3000-2000 1.62%, 2000-1000 7.89%, 1000-500 23.90%, and <500 66.52%.
[46] Table 1 Amino acid content table Amino acid name Content (g/100 g) Amino acid name Content (g/100 g) Aspartic acid 9.4134 Threonine 6.1534 Serine 5.4371 Glutamic acid 11.8370 Glycine 1.2915 Alanine 5.2508 Cystine 1.0315 Valine 5.5380 Methionine 1.1595 Isoleucine 5.1048 Leucine 10.2868 Tyrosine 1.1821 Phenylalanine 2.4206 Lysine 7.7838 Histidine 1.2576 Arginine 2.0361 Proline 6.1206 Total amino acid 83.3046
[47] Example 2
[48] A preparation method of a compound protein powder was provided:
[49] The compound protein powder included the following components according to mass ratio: 66.74 g of a whey protein, 30.2 g of the whey protein peptide prepared in Example 1, 1.5 g of a collagen peptide, 1.5 g of a food flavor and 0.06 g of a sucralose; the components were subjected to rotary mixing and stirring to obtain the compound protein powder.
[50] The preparation method included:
[51] (1) pre-mixing: four components, the whey protein peptide, the collagen peptide, the food flavor and the sucralose were weighed in proportions separately, and passed through a 30-mesh sieve to obtain a primary mixture;
[52] (2) mixing: the primary mixture obtained in step (1) was slowly added to warm water (at pH 6.0) at 45°C in a weight ratio to water of 1:5, uniformly stirred at a rate of 70 rpm, and the whey protein was added for mixing evenly;
[53] (3) a product obtained in step (2) was frozen and vacuum-dried (using a YRDS-15010 Chinese-style freeze dryer for health products and foods) at a temperature of -40°C to -45°C and a vacuum degree of 220 Pa for 46 h; and
[54] (4) a product obtained in step 3) was pulverized through a 40-mesh sieve with a WN-500A pulverizer to obtain the compound protein powder.
[55] Example 3
[56] 1. Specified pathogen free-grade (SPF-grade) C57 mice were taken as model mice and randomly divide into 4 groups: a control group (group A), a testosterone group (group B), a compound protein powder group (the compound protein powder of Example 2, group C) and a whey protein peptide group (the whey protein peptide of Example 1, group D), and a gavage dose was 300 mg/kg. Each experimental group was subjected to resistance exercise with weight-bearing ladder crawling for 8 weeks. The grip strength of forelimbs before and after the experiment was ) detected. At the end of the experiment, the experimental mice were sacrificed, and the serum and rectus femoris were taken for later use.
[57] 2. Determination of grip strength
[58] The experimental mice were grasped and placed on a grip strength plate with the right hand, a tension plate was pushed forward with the left hand, and the right hand slid back to the mouse tail; pulled back the mice in time when the mice grasped the grip strength plate hard to measure the maximum grip strength of the mice.
[59] The results were shown in Table 2 and FIG. 2. The whey protein peptide can significantly improve the grip strength of the forelimbs of mice with an effect better than that of the compound protein powder group and the testosterone group. The grip strength of the mice in the compound protein powder group is significantly improved compared with that of the normal group. Table 2 Effect of proteins on the grip strength of the forelimbs of mice in different groups
Item Group A Group B Group C Group D
Initial grip strength (g) 136.6+8.9 139.3+10.1 141.9+12.3 137.1+9.5
Grip strength after 8 weeks 206.2+15.2 277.5±27.3 261.5+23.1 289.9+25.6
[60] 3. Determination of testosterone and IGF-1
[61] The experimental mouse serum was taken to detect the content of testosterone and IGF-1 separately according to operating instructions of an enzyme-linked immunosorbent assay (ELISA) kit.
[62] Testosterone is very closely-related to muscle growth, and high-level testosterone can significantly reduce protein degradation. Moreover, increasing the testosterone level can effectively reduce fat. The experimental results were shown in FIG. 3. Compared with the control group, taking whey protein peptide can significantly increase the testosterone level of mice, and the testosterone level is significantly higher than that of the mice in the normal group, the testosterone group and the compound protein powder group. The testosterone level of mice in the compound protein powder group is significantly higher than that in the normal group.
[63] IGF-1 is a key positive regulator in the skeletal muscle regeneration and is important in promoting the skeletal muscle growth. FIG. 4 shows that compared with the control group, taking the whey protein peptide can significantly increase the content of IGF-1 in the peripheral blood of mice, with an increase higher than that of the compound protein powder group and the testosterone group.
[64] 4. Determination of gastrocnemius cross-sectional area
[65] The gastrocnemius cross-sectional area ([m2 ) of the medial gastrocnemius of the mice in different groups was observed using a staining method.
[66] The increase in the gastrocnemius cross-sectional area is the most intuitive manifestation of muscle growth, and the increase of the muscle cross-sectional area is significantly positively-correlated with the increase of the muscle strength. Table 3 shows that compared with the control group, taking the whey protein peptide can significantly promote the growth of gastrocnemius with an increase higher than that of the compound protein powder group and the testosterone group.
[67] Table 3 Influence of different proteins on the gastrocnemius cross-sectional area
Item Group A Group B Group C Group D
Gastrocnemius 3092.3+265.3 6318.9+377.4 5873.2+346.1 7156.4+462.5 cross-sectional area (m 2 )
[68] 5. Determination of ATPase activity
[69] Ice physiological saline was added to a fresh muscle tissue, and liver tissues were cut up as soon as possible with small ophthalmic scissors. The chopped muscle tissue was poured into a glass homogenization tube, the fragments of tissue remaining in a beaker were rinsed using the remaining 1/3 ice physiological saline, and poured into the glass homogenization tube together for homogenization; the lower end of the glass homogenization tube was inserted by the left hand into a beaker containing an ice-water mixture, and a ramming rod was inserted vertically into a casing with the right hand; grinding was thoroughly conducted by rotating up and down for dozens of times (for 6-8 minutes) to homogenize the muscle tissue (10% tissue homogenate). Centrifugation was conducted to obtain a supernatant, and the ATPase activity in the mitochondria of rectus femoris tissue was determined according to the steps of an ATPase kit operating instruction.
[70] Mitochondria are the main place to synthesize ATP, and the ATP is the energy required for body movement. A high-energy phosphate bond may be hydrolyzed by an ATP hydrolase to generate a free ATP to provide energy for body activities. Compared with the control group and the compound protein powder group, the whey protein peptide can significantly increase the ATP hydrolase activity in skeletal muscle mitochondria (FIG. 5).
[71] 6. Effect of the whey protein peptide on insulin signaling pathways
[72] Insulin signaling pathway is important in the muscle growth. In this study, the effect of the whey protein peptide on the insulin signaling pathway was detected using the Western blot. The operation method specifically includes: triceps surae of an experimental rat was homogenized, cells were sonicated, a loading buffer was added, protein separation was conducted by a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), electric rotation was conducted at
350 mA for 2.5 hours; a polyvinylidene fluoride (PVDF) membrane was taken out, and blocked with a 5% skimmed milk powder at room temperature for 1 hour; the membrane was washed with a Tris-buffered saline with Tween-20 (TBS-T) for 3 times, a primary antibody was added for incubation overnight at 4°C; the membrane was washed with TBS-T for 3 times, a secondary antibody was added for incubation at room temperature for 1 hour; the membrane was washed, and an electrochemical luminescence (ECL) luminescent agent was added to develop color.
[73] Insulin-like growth factor (IGFs) signaling pathway is important in muscle growth and damage repair. The results are shown in FIG. 6. The whey protein peptide can significantly increase the expression of IGF-1R, thereby promoting the binding of IGF-1 and IGF-1R, and further promoting the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK). In addition, the up-regulated expression of cell cycle-related proteins cyclinD1 and CDK6 are induced, which eventually leads to cell proliferation.
[74] The above descriptions are merely preferred implementations of the present disclosure. It should be noted that a person of ordinary skill in the art may further make several improvements and modifications without departing from the principle of the present disclosure, but such improvements and modifications should be deemed as falling within the protection scope of the present disclosure.
Claims (5)
1. A preparation method of a whey protein peptide, comprising the following steps: (1) preparing a whey protein powder into a whey protein aqueous solution, adjusting a pH of the whey protein aqueous solution to 8.5-8.8, and conducting heat preservation at 53-56°C for 25-30 min to obtain a homogenate; wherein the whey protein powder and water in the whey protein aqueous solution have a mass-to-volume ratio of 1 kg: (8-12) L; and (2) conducting enzymolysis on the homogenate using a papain and a flavor protease, decolorizing and deodorizing after enzyme deactivation, collecting a submembrane liquid of a 1 kDa organic membrane to obtain the whey protein peptide.
2. The preparation method according to claim 1, wherein in step (1), a preparation method of the whey protein aqueous solution comprises: dissolving 30-50% of the whey protein powder with -50% water, stirring uniformly and adding the remaining water and whey protein powder; wherein in step (1), the pH is adjusted to 8.5-8.8 using a NaOH solution with a concentration of 10 mol/L; wherein in step (2), the papain is 0.8-1.2% the mass of the whey protein powder, and the flavor protease is 0.4-0.6% the mass of the whey protein powder; wherein in step (2), the enzymolysis comprises: mixing the homogenate with the papain for enzymolysis for 3 h, and then with the flavor protease for enzymolysis for 2 h; wherein in step (2), the decolorizing and deodorizing is conducted with an activated carbon; and a decolorized and deodorized enzyme deactivation liquid is passed through a ceramic membrane with a molecular weight cut-off of 30,000 Da and an organic membrane with a molecular weight cut-off of 1,000 Da sequentially, and the submembrane liquid is collected; further comprising: spray drying after collecting the submembrane liquid.
3. A whey protein peptide obtained by the preparation method according to any one of claims 1-2, wherein a branched chain amino acid in the whey protein peptide has a mass percentage of equal to or more than 20%.
4. A compound protein powder with a muscle-building effect, comprising a whey protein, a collagen peptide, a food flavor, a sucralose and the whey protein peptide according to claim 3.
5. The compound protein powder according to claim 4, comprising the following components by mass percentage: the whey protein 60-70%, the whey protein peptide 25-36%, the collagen peptide 1-2%, the food flavor 1-2% and the sucralose 0.04-0.1%.
-1/3-
DRAWINGS 24 Aug 2021
Shandong Tianheng Inspection Co., Ltd. Test Report Report No.: SP2021-0220006 Sample No.: N20210220006 1/1 Page Inspection department: Zhongshiduqing (Shandong) Biotech Co., Ltd. Sample name: Whey protein peptide 2021106749
Results of hydrolysis of amino acids:
Amino acid name Content (g/100 g) Amino acid name Content (g/100 g)
Aspartic acid 9.4134 Threonine 6.1534
Serine 5.4371 Glutamic acid 11.8370
Glycine 1.2915 Alanine 5.2508
Cystine 1.0315 Valine 5.5380
Methionine 1.1595 Isoleucine 5.1048
Leucine 10.2868 Tyrosine 1.1821
Phenylalanine 2.4206 Lysine 7.7838
Histidine 1.2576 Arginine 2.0361
Proline 6.1206 Total amino acid 83.3046 Molecular weight results: Peak area percentage (%, λ220 nm) >3000 0.07 2000-3000 1.62 1000-2000 7.89 500-1000 23.90 <500 66.52 Examination by Shandong Tianheng Inspection Co., Ltd. Checked by (sealed) Issued Date 2021-02-26 FIG. 1
-2/3- 24 Aug 2021 2021106749
Initial grip After 8 weeks of strength resistance exercise Grip strength of mice (g)
Group A Group B Group C Group D
FIG. 2 Testosterone content of mice (control multiple)
Group A Group B Group C Group D
FIG. 3
-3/3- 24 Aug 2021
IGF-1 content (pg/ml) 2021106749
Group A Group B Group C Group D
FIG. 4 ATPase activity
Group A Group B Group C Group D
FIG. 5
Group A Group B Group C Group D
FIG. 6
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021106749A AU2021106749A4 (en) | 2021-08-24 | 2021-08-24 | Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021106749A AU2021106749A4 (en) | 2021-08-24 | 2021-08-24 | Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021106749A4 true AU2021106749A4 (en) | 2021-11-18 |
Family
ID=78514068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021106749A Active AU2021106749A4 (en) | 2021-08-24 | 2021-08-24 | Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021106749A4 (en) |
-
2021
- 2021-08-24 AU AU2021106749A patent/AU2021106749A4/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Effects of different ultrasound powers on the structure and stability of protein from sea cucumber gonad | |
Jin et al. | Preparation of antioxidative corn protein hydrolysates, purification and evaluation of three novel corn antioxidant peptides | |
Liu et al. | Antioxidant activity and stability study of peptides from enzymatically hydrolyzed male silkmoth | |
EP0704218B1 (en) | Bone reinforcing agent and foods and drinks product containing the same | |
Guo et al. | Purification and identification of antioxidant peptides from Chinese cherry (Prunus pseudocerasus Lindl.) seeds | |
Fadimu et al. | Improving the enzymolysis efficiency of lupin protein by ultrasound pretreatment: Effect on antihypertensive, antidiabetic and antioxidant activities of the hydrolysates | |
Lv et al. | The positive effect of soybean protein hydrolysates—calcium complexes on bone mass of rapidly growing rats | |
Ali et al. | Soymilk-Cow’s milk ACE-inhibiting enzyme modified cheese | |
CN111718825A (en) | Sturgeon bone peptide wine with effects of tonifying kidney and benefiting yang as well as preparation method and application thereof | |
Abachi et al. | Isolation of immunomodulatory biopeptides from Atlantic Mackerel (Scomber scombrus) protein hydrolysate based on molecular weight, charge, and hydrophobicity | |
CN107674905A (en) | Spirulina bioactive peptide, composition and preparation method | |
AU2021106749A4 (en) | Whey protein peptide with muscle-building effect and preparation method thereof, and compound protein powder | |
Gan et al. | Isolation, characterization, and molecular docking analyses of novel calcium‐chelating peptide from soy yogurt and the study of its calcium chelation mechanism | |
WO2021082311A1 (en) | Pea peptide having supplementary blood glucose reducing function and preparation method therefor | |
Yu et al. | Osteogenic activities of four calcium‐chelating microalgae peptides | |
AU2021106754A4 (en) | Preparation method and use of pea peptide with muscle-building effect | |
JP6609083B1 (en) | Food composition, food and drink, supplement, and agent | |
US11951155B2 (en) | Pea-derived peptide with muscle-building effect and preparation method thereof, and drug and use | |
CN103262939A (en) | Preparation method of antioxidant activity mixed peptide originated from chick embryo | |
US10941432B1 (en) | Method for the preparation of low molecular weight porcine lympho-reticular polypeptides | |
CN115969961A (en) | Calcium, VD and protein peptide composition for improving bone mineral density and preparation method and application thereof | |
CN113122604B (en) | Sea intestine glue and preparation method and application thereof | |
CN106701870B (en) | Preparation method of small black soybean whey polypeptide powder with anti-tumor effect | |
CN110699410B (en) | Preparation method of euphausia superba small-molecule peptide | |
CN107099571A (en) | A kind of bionic enzymatic prepares the production method of silkworm chrysalis small peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) |